Retrospective Study: Evaluation of Antiretroviral Adherence During Pregnancy and Postpartum Using Electronic Monitoring Data
Overview
- Phase
- Not Applicable
- Intervention
- Not specified
- Conditions
- HIV Infection
- Sponsor
- Center for Primary Care and Public Health (Unisante), University of Lausanne, Switzerland
- Enrollment
- 26
- Locations
- 1
- Primary Endpoint
- Change in patient adherence during pregnancy and postpartum
- Status
- Completed
- Last Updated
- 10 years ago
Overview
Brief Summary
The purpose of this study is to compare adherence to antiretroviral therapy during pregnancy and postpartum, and to record adherence barriers and facilitators.
Detailed Description
Data of all consecutive pregnant women included in the adherence enhancing program of the Pharmacy, Department of ambulatory care \& community medicine, are collected. In this program, adherence is measured and enhanced by electronic monitoring, pill count, motivational interviewing and interdisciplinary collaboration. Electronic monitoring data are collected during pregnancy and postpartum, and compared. Barriers and facilitators are collected using interview's marks.
Investigators
Marie Schneider
Pharmacist, PhD
Center for Primary Care and Public Health (Unisante), University of Lausanne, Switzerland
Eligibility Criteria
Inclusion Criteria
- •Pregnant Women
- •HIV-positive
- •Antiretroviral medication delivered in electronical monitors
Exclusion Criteria
- •Monitored period during pregnancy \< 1 month
Outcomes
Primary Outcomes
Change in patient adherence during pregnancy and postpartum
Time Frame: before delivery (1 to 9 month) and postpartum (6 month)
By electronic drug monitoring, pill count and subject interviews' marks
Secondary Outcomes
- Adherence barriers and facilitators(pregnancy and postpartum (6 months))